BioCentury
ARTICLE | Company News

Biopharm, Orquest deal

April 10, 2000 7:00 AM UTC

Orquest and Biopharm will exclusively develop products combining growth factors with bioengineered matrices for spine, fracture, dental and cartilage repair. Biopharm will contribute its MP52 recombin...